Mindmed: Eight Capital Resumes Coverage With $6.50 Price Target
Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer during the summer months. They say that after a large influx of capital and “a growing body of clinical trial data on the use of psychedelics and related substances demonstrating a remarkable degree of […]
Canadian Housing Starts Slump in August as Construction Continues to Slow
The pace of housing starts across Canada slowed in August, as new construction continues to decline from previous record-highs. According to the CMHC, the adjusted annual rate of housing starts slumped from 270,744 units in July to 260,239 units last month, marking a decrease of 3.9%. Urban starts fell 4.7% in August to 235,782 units, […]
George Adams: COVID-19 Damages The Heart – The Daily Dive
Today’s Daily Dive welcomes back Dr. George Adams, Executive Chairman of VentriPoint Diagnostics (TSXV: VPT). He expounds on salient topics including the effect of COVID-19 on the heart’s health, the role of an improved cardiovascular healthcare system during the pandemic, and the involvement of the company’s echocardiogram innovation within that space. The biotech firm’s chief […]
Docebo Conducts $112 Million Secondary Bought Deal Offering
Docebo Inc. (TSX: DCBO) announced Thursday night an agreement with select selling shareholders to conduct a secondary offering on a bought deal basis. The aggregate proceeds are reported to be $112 million. The offering consists of 1.0 million common shares at $112.00 per share made by the company’s shareholders: Docebo CEO Claudio Erba, Docebo President […]
Cathie Wood Has Sold $266 Million of Tesla Stock in September Despite $3,000 Price Target
Cathie Wood has sold even more Tesla (NASDAQ: TSLA) stock this week, offloading another 81,600 shares on Wednesday despite affirming a price target of $3,000 for her beloved EV maker. According to Bloomberg, Wood’s ARK Innovation (NYSE: ARKK) and ARK Next Generation Internet (NYSE: ARKW) ETFs liquidated more than 81,600 Tesla shares on Wednesday, totaling […]
Eight Capital Initiates Coverage On Field Trip Health With $10.20 Price Target
Earlier this week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after they produced an industry primer during the summer months. The third company on this list is Field Trip Health (CSE: FTRP) with a C$10.20 12-month price target and buy rating. Field Trip Health currently has 3 analysts covering the […]
Kyrgyzstan Adds Former Centerra Gold Officers To Wanted List, Detains Former Prime Minister Related To Kumtor Mine Case
Former officers of Centerra Gold Inc. (TSX: CG) and the Kumtor Gold Company have been added to Kyrgyzstan’s wanted list related to its ongoing investigation in the alleged corruption enveloped in the highly contested Kumtor mine. The country’s law enforcers also detained another former prime minister as part of the high-profile case. The nation’s State […]
Europe Faces Record Natural Gas Hyperinflation as Hedge Funds Prepare to Profit
Natural gas prices across Europe have been sent skyrocketing as of late, amid a combination of low storage volumes, cooler weather, and bureaucratic setbacks. European gas prices have surged into hyperinflationary territory, sparking mass protests across the bloc area on a daily basis. Indeed, it appears that the cost of living across Europe will especially […]
High Tide Continues Ontario Expansion With 24th Store In Glueph
Within a month from putting up its first store in Brampton, High Tide Inc. (TSXV: HITI) announced today that its Canna Cabana retail cannabis store in Glueph is now operational. The newly opened store is the company’s 24th in the province of Ontario and 95th in the country. “With the opening of this new Guelph […]
BioVaxys Sees Manufacturing Partner Reach Bioproduction Milestone For Ovarian Cancer Vaccine
BioVaxys Technology Corp. (CSE: BIOV) announced this morning that its France-based manufacturing partner, Bio Elpida, has reached milestones in its bioproduction process related to the company’s ovarian cancer vaccine. The partnership is currently working on the biotech firm’s cancer vaccine candidate BVX-0918A. Bio Elpida has recently concluded technology process transfer with BioVaxys and is expected […]